#her2 breast cancer

New Role Discovered for Mutant Protein Found in Most Breast Cancers

3d rendering medical illustration of the human breast

Some Postmenopausal Women Can Skip Additional Chemotherapy

October is Breast Cancer Awareness Month

Breast Cancer 101

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

Breast Cancer Riddle: Best Ways to Screen and Treat

Laura J. Esserman, MD, of the University of California, San Francisco, explains how to improve breast cancer screening practices.

Why Are Clinical Trials So Important in Breast Cancer Treatment?

University of Colorado’s Jennifer Diamond, MD, talks about how clinical trials work in breast cancer and what they can do for patients.

Lessons on Cancer Survivorship From the Front Lines

As a family medicine physician and a breast cancer patient, Cheryl Law shares how she navigates her own treatment.

Therapy for Small, HER2-Positive Breast Tumors Is Highly Effective After 10 Years

Dana-Farber breast cancer researchers performed genomic testing, yielding findings may help personalize treatment in the future.

Latest Advances in Breast Cancer

Check out these promising breast cancer studies.

Some cancer drugs target tumors that overexpress HER2 proteins.

Tukysa and Herceptin Combo OK’d for HER2-Positive Colorectal Cancer

This treatment represents a “fairly substantial breakthrough” for patients with HER2-positive advanced colorectal cancer.

Trodelvy for Metastatic Breast Cancer

Patients treated with Trodelvy had a 21% reduction in the risk for death.

Enhertu Improves Survival for Women with HER2-Positive Breast Cancer

Research also showed that treatment before surgery benefits patients with HER2-low breast cancer.

HER2-Low Breast Cancer

The results could also be relevant for people with other types of HER2-low cancer.

Enhertu Works for HER2-Low Metastatic Breast Cancer Too

The antibody-drug conjugate improved progression-free and overall survival for patients with low HER2 expression on breast tumors.

New Findings About Breast Cancers With Low Levels of HER2 Protein

Researchers at Dana-Farber Cancer Institute show that “HER2-low” tumors are not a distinct subtype of breast cancer.

Using Big Data to Better Understand Cancerous Mutations

Artificial intelligence and machine learning can help identify genetic changes that lead to cancer—and which treatments work best.

New Biomarker Classification May Improve Treatment of High-Risk Breast Cancer

The new cancer subtypes help better characterize a person’s tumor. The goal is to get the right drug to the right patient.

When Breast Cancer Spreads to the Brain: What You Need to Know

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.

Now Approved

Here are latest cancer drugs approved by the Food and Drug Administration.

#her2 breast cancer

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

Breast Cancer Riddle: Best Ways to Screen and Treat

Why Are Clinical Trials So Important in Breast Cancer Treatment?

Lessons on Cancer Survivorship From the Front Lines

Therapy for Small, HER2-Positive Breast Tumors Is Highly Effective After 10 Years

Latest Advances in Breast Cancer

Tukysa and Herceptin Combo OK’d for HER2-Positive Colorectal Cancer

Trodelvy for Metastatic Breast Cancer

Enhertu Improves Survival for Women with HER2-Positive Breast Cancer

HER2-Low Breast Cancer

Enhertu Works for HER2-Low Metastatic Breast Cancer Too

New Findings About Breast Cancers With Low Levels of HER2 Protein

Using Big Data to Better Understand Cancerous Mutations

New Biomarker Classification May Improve Treatment of High-Risk Breast Cancer

When Breast Cancer Spreads to the Brain: What You Need to Know

Now Approved

Margenza

Science News

Features